The Patent Finder
US

Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders

US 7,803,931 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Feb 14, 2025 · Medium confidence

Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 7,579,456), so the cap could be lower.

Filed Feb 14, 2005 as application 11/058,134 · Granted Sep 28, 2010
Base term plus 84 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
Term ended Feb 14, 2025
2005 2026
Clock starts
Feb 14, 2005
Term ended
Feb 14, 2025
Granted
Sep 28, 2010
base term after the term ends fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
84
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 7,538,211, US 7,579,456.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 84 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Feb 14, 2005, when this application, 11/058,134, was filedFeb 14, 2025High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+84 days, USPTO patent term adjustment recordMay 9, 2025High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,538,211, US 7,579,456)capped to Feb 14, 2025Medium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderFeb 14, 2025Medium confidence

This family

US 7,803,931this patent
Feb 2025
Feb 2025
US 7,538,211Term ended
Feb 2025
Feb 2025
US 7,579,456Term ended
no later than Feb 2025
no later than Feb 2025
US 8,236,773Term ended
Nov 2026
Nov 2026
US 8,436,164Term ended
Feb 2025
Feb 2025
US 9,617,546Term ended
no later than Feb 2025
no later than Feb 2025
US 10,947,544Term ended
Feb 2025
Feb 2025
US 11,913,000Term ended
Apr 2025
Apr 2025
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 30, 2005
Reel 17043, frame 556
Benedict, Claude; Diener, John; Epstein, David; Grate, Dilara; Keene, Sara Chesworth; Kurz, Jeffrey; Kurz, Markus; McCauley, Thomas Greene; Rottman, James; Wilson, Charles; Zoltoski, Anna J.; Thompson, KristinArchemix CorporationAssignment of Assignor's Interest
Jan 10, 2012
Reel 27510, frame 478
Archemix Corp.Archemix LLCMerger
Aug 5, 2022
Reel 61088, frame 48
Iveric Bio, Inc.Hercules Capital, Inc.Security Interest
Jul 17, 2023
Reel 64286, frame 472
Hercules Capital, Inc.Iveric Bio, Inc.; Iveric Bio Gene Therapy LLC; Orion Ophthalmology LLCRelease of Security Interest
Jul 17, 2023
reel/frame not recorded
Hercules Capital, Inc.Iveric Bio, Inc.Release of Security Interest
Jul 17, 2023
reel/frame not recorded
Hercules Capital, Inc.Iveric Bio Gene Therapy LLCRelease of Security Interest
Jul 17, 2023
reel/frame not recorded
Hercules Capital, Inc.Orion Ophthalmology LLCRelease of Security Interest
Sep 7, 2023
Reel 64833, frame 421
Archemix LLCIveric Bio., Inc.Assignment of Assignor's Interest
Jun 26, 2024
Reel 67851, frame 643
Iveric Bio, Inc.Astellas US LLCMerger

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited